AbbVie, Akcea benefit from latest CHMP recommendations

AbbVie, Akcea benefit from latest CHMP recommendations

Submitted by admin on March 3, 2019 - 7:12pm
Source: 
Biopharma Dive
News Tags: 
Europe
CHMP
AbbVie
Akcea
Biomarin
Sanofi
Pfizer
drug approvals
Headline: 
AbbVie, Akcea benefit from latest CHMP recommendations
snippet: 

Eight more drugs have received approval recommendations from the committee that advises European regulators on what therapies to clear for market.

Do Not Allow Advertisers to Use My Personal information